Quantcast

Latest biotechnology Stories

2014-10-14 23:09:20

Selexis has promoted director of European business development, Marco Bocci, PhD, PharmD, to Vice President, European Licensing and Business Development for Europe. Geneva, Switzerland (PRWEB) October 14, 2014 Selexis SA, a serial innovation company with proven technologies for biologic drug discovery and mammalian cell line development, has promoted director of European business development, Marco Bocci, PhD, PharmD, to Vice President, European Licensing and Business Development. Bocci...

2014-10-14 20:22:09

LONDON, Oct. 14, 2014 /PRNewswire/ -- This BCC Research study offers an overview of the multiple sclerosis (MS) disease-modifying product market, including regulatory issues accompanied by detailed analyses and forecasts by product. Its main objective is to present a comprehensive analysis of the current market for MS disease-modifying products and to forecast this marketâEUR(TM)s future direction through 2018. Special focus is placed on how new products and technologies will affect...

2014-10-14 16:27:06

LONDON, Oct. 14, 2014 /PRNewswire/ -- Synthetic biology is an emerging biotechnology discipline with a wide range of applications. This BCC Research report determines the specific applications and forecast global market demand for synthetic biology products through 2018. This analysis provides a quantitative basis and market context for companies to make strategic choices about participation in the synthetic biology industry.Synthetic biology technologies, growth driving forces,...

2014-10-14 16:25:36

LONDON, Oct. 14, 2014 /PRNewswire/ -- REPORT HIGHLIGHTSBCC Research estimates that the global demand for bioproducts will increase at a double-digit compound annual growth rate (CAGR) of 12.6% over the next five years to reach $700.7 billion in 2018 from $387.6 billion in 2013, when it will attain a market penetration rate of 5.5% in 2018, from an estimated rate of 4.2% in 2013. This report provides:A complete techno-economic and environmental analysis of industrial biorefinery...

2014-10-14 16:25:31

LONDON, Oct. 14, 2014 /PRNewswire/ -- This report provides readers with a detailed analysis of the global biopesticides industry from 2014 through 2019. It also discusses its technological developments, future trends and emerging opportunities. It organizes information from diverse sources into a cohesive unit that includes overview of pesticide (synthetic and biopesticide) market, organic farming and production, industry structure, and technology and patents sections. CAGR...

2014-10-14 16:22:24

LONDON, Oct. 14, 2014 /PRNewswire/ -- Widespread research in the field of industrial enzymes has revealed the influence of enzyme technology in almost every sector of industrial activity, ranging from technical field to food, feed and healthcare activity. This BCC Research report provides an overview of the current and future characteristics of the global market for industrial enzymes. Enzymatic processes are rapidly becoming better financial and ecological alternatives to chemical...

2014-10-14 08:33:06

-- CIAO!(TM) Technology Maximizes Selectivity of Conditionally Active Antibodies -- SAN DIEGO, Oct. 14, 2014 /PRNewswire/ -- BioAtla, a global biotechnology company focused on the development of Conditionally Active Biologics (CABs), today announced that the United States Patent and Trademark Office (USPTO) has issued to BioAtla U.S. Patent No. 8,859,467, for its proprietary Comprehensive Integrated Antibody Optimization(TM) (CIAO!(TM)) technology platform. The BioAtla CIAO patent...

2014-10-14 08:31:25

DUBLIN, Oct. 14 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Europe Biosimilars Market & Pipeline Insight" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Biosimilars have emerged as one of the most promising segment of the European pharmaceutical industry in recent years. The biosimilars segment has been experiencing a steady growth driven by patent expiration of blockbuster drugs, amenable regulatory framework, economic...

2014-10-14 08:31:13

--Sales of Rubicon Genomics' DNA Library Prep Kit Products Increase over 50% as Expansion of Distribution Channels Continues-- ANN ARBOR, Mich., Oct. 14, 2014 /PRNewswire/ -- Rubicon Genomics, Inc., today announced that it has signed agreements with new distributors in Europe, North Africa and Asia to further expand the availability of its DNA library preparation products for arrays and Illumina(®) next-generation sequencing (NGS) platforms, including ThruPLEX(® )DNA-seq,...

2014-10-14 08:31:11

BOSTON, Oct. 14, 2014 /PRNewswire/ -- Boston Strategics Corporation (BSC), an integrated clinical-stage drug research and development (R&D) company, Boston, MA, today announced that it has entered into an agreement with Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics. In collaboration with MRL, BSC designs and manages for pharmaceutical drug development programs to...


Latest biotechnology Reference Libraries

GloFish
2013-10-03 10:12:03

The GloFish is a patented and trademarked brand of genetically modified fluorescent fish. Various GloFish are currently on the market. Zebrafish were the first GloFish that were available within pet stores and are now sold in bright green, red, orange-yellow, blue, and purple fluorescent colors. Recently, Electric Green, Sunburst Orange, and Moonrise Pink colored tetra (Gymnocorymbus ternetzi) and Electric Green tiger barb (Puntius tetrazona) have been incorporated to the lineup. Although not...

Flavr Savr
2013-10-03 09:43:32

Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...

Knockout Mouse
2013-10-02 11:52:01

A Knockout Mouse is a genetically engineered mouse in which researchers have inactivated, or “knocked out,” an existing gene by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity frequently causes changes in a mouse’s phenotype, which includes appearance, behavior, or other apparent and biochemical characteristics. Knockout mice are significant animal models for studying the role of genes which have been sequenced but whose functions haven’t...

Genetically Modified Wheat
2013-10-02 07:20:35

Genetically Modified Wheat is wheat that has been genetically engineered by the direct manipulation of its genome utilizing biotechnology. It has also been termed GMO wheat, GMO standing for genetically modified organism. As of the year 2013, no GM wheat is grown commercially, but many field tests have been performed. Wheat is an important domesticated grass that is used around the world for food, and its evolution has been influenced by human intervention since the dawn of agriculture....

Biotechnology and Applied Biochemistry
2012-06-04 19:33:04

Biotechnology and Applied Biochemistry is a peer-reviewed academic journal established in 1979 under the title Journal of Applied Biochemistry and published by Academic Press. It assumed its present title in 1986 and publication was taken over by Portland Press in 1993. It is now published bimonthly by Wiley-Blackwell (since 2011). It is the official journal of the International Union of Biochemistry and Molecular Biology. The journal publishes scholarly Articles and Reviews relating to...

More Articles (7 articles) »
Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related